Skip to main content

FDA Approvals

FDA Approvals, In the News
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Read More
FDA Approvals, In the News
Mixed Findings in Annual Cancer Statistics Report
Read More
FDA Approvals, In the News
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
FDA Approvals, In the News
Recap of FDA Drug Approvals in 2019
Read More
FDA Approvals, In the News
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
FDA Approvals
FDA Oncology Update
Read More
FDA Approvals, In the News
November 11, 2019 — Oncology News & Updates
Read More
FDA Approvals, In the News
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Oncology
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
FDA Approvals, Multiple Myeloma, In the News, Oncology
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Read More
Page 19 of 53
Results 181 - 190 of 524